相关实验视频

Updated: Jan 7, 2026

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

疹尿液对LPS挑战的角质细胞的抗炎作用

Carla Marrassini¹, María Laura Barreiro Arcos², Laura Cogoi¹

¹Pharmacognosy, Faculty of Pharmacy and Biochemistry, IQUIMEFA UBA CONICET, University of Buenos Aires, Buenos Aires, Argentina.

Journal of pharmacopuncture

|January 1, 2026

概括

疹尿液提取物通过减少皮肤细胞中的氧化和细胞因子,显示出抗炎作用. 这种植物提取物在体外还显示了加速伤口愈合的潜力,这表明在炎症性皮肤疾病中具有治疗效益.

科学领域:

皮肤病学皮肤病学
药理学药理学是指药理学的学科.
免疫学免疫学免疫学

背景情况:

角质细胞是保护皮肤免受环境威胁的关键皮肤细胞,但可以过度反应,导致炎症性皮肤疾病.
皮肤中的炎症反应失调有助于诸如牛皮,癌症和衰老等疾病.
疹尿液,以民间的抗炎用途而闻名,在全球范围内发现.

研究的目的:

为了研究疹尿液乙醇提取物的抗炎潜力.
评估提取物对氧化物 (NO) 生产和皮细胞中促炎性细胞因子表达的影响.
为了评估提取物对体外伤口愈合的影响.

主要方法:

采用了使用脂多糖 (LPS) 刺激的角质细胞的体外模型.
对Urtica urens提取物的分析确定了多,黄和酸.
该研究测量了氧化水平,促炎性细胞因子释放 (IL-6,TNF-α,IL-1β) 和伤口关闭率.

主要成果:

疹尿液提取物显著降低了LPS诱导的氧化产量.
提取物抑制了关键的促炎细胞因子 (IL-6,TNF-α,IL-1β) 的释放.
实验室研究表明,提取物加速了伤口的关闭.

结论:

疹尿液提取物具有显著的抗炎性质.
提取物有效调节皮肤炎症的关键媒介.
疹尿液提取物显示出作为治疗慢性炎症性皮肤疾病的局部治疗的希望.

关键词:

这是RT-PCR.细胞因子细胞因子这是一种炎症炎症炎症炎症.自然化合物自然化合物皮肤皮肤皮肤伤口愈合伤口愈合

更多相关视频

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Published on: May 28, 2021

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms: